Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Remestemcel-L by Mesoblast for Graft Versus Host Disease (GVHD): Likelihood of Approval
Remestemcel-L is under clinical development by Mesoblast and currently in Pre-Registration for Graft Versus Host Disease (GVHD). According to GlobalData,...
Rexlemestrocel-L by Mesoblast for Hypoplastic Left Heart Syndrome: Likelihood of Approval
Rexlemestrocel-L is under clinical development by Mesoblast and currently in Phase II for Hypoplastic Left Heart Syndrome. According to GlobalData,...
Rexlemestrocel-L by Mesoblast for Congestive Heart Failure (Heart Failure): Likelihood of Approval
Rexlemestrocel-L is under clinical development by Mesoblast and currently in Phase III for Congestive Heart Failure (Heart Failure). According to...